Effects of Abaloparatide-SC on Bone Mineral Density and Risk of Fracture in Postmenopausal Women Aged 80 Years or Older with Osteoporosis

OBJECTIVE: Advanced age is an important risk factor for fracture. The ACTIVE (Abaloparatide Comparator Trial In Vertebral Endpoints) trial showed that abaloparatide-SC increased bone mineral density and reduced the risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Menopause
Main Authors: McClung, Michael R., Harvey, Nicholas C., Fitzpatrick, Lorraine A., Miller, Paul D., Hattersley, Gary, Wang, Yamei, Cosman, Felicia
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015760/
https://ncbi.nlm.nih.gov/pubmed/29462094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001080
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados